MEPERIDINE HYDROCHL
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency has awarded DMS Pharmaceutical Group Inc under contract SPE2DP26F1413, issued on July 21, 2026, for the delivery of meperidine hydrochloride identified by NSN 6505015054693. This award is issued as a delivery order under the parent contract SPE2DX25D9900 and is classified as a federal transaction with no specific set-aside designation. The total contract value is detailed in the award documentation, and the item is intended for federal use without publicly listed place of performance or point of contact information. The award was posted via the DIBBS system, and the official record can be accessed through the provided UI link, confirming the transaction’s alignment with Department of Defense procurement protocols.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(2)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
